Ann: First AngelMed Guardian implants in Asia-Pacific, page-179

https://www.thesentiment.com.au/hydrix-successfully-implants-heart-attack-warning-device-in-four-patients/

i would recommend everyone to have read of this article as anyone can analyse the all short to medium term price sensitive markers.

" The four patients in Singapore will meet with Dr Lam in two weeks which will give the devices time to gather sufficient data on the patients’ baseline heart signal. This data will then enable Hydrix Medical engineers to customise alert signals allowing artificial intelligence to enable the device, warning of acute coronary syndrome events, including salient heart attacks. 
While the AngelMed Guardian is approved for commercialisation in the United States, it has yet to be signed off in Australia by the Therapeutic Goods Association. However, Hydrix Medical is hoping to reach regulatory arrangements under the TGA’s Special Access Scheme. If regulatory requirements can be met, Hydrix is aiming to commence implants in Australia before the end of 2020 "